CV Lattes
Secretaria da Saúde (São Paulo - Estado). Coordenadoria de Serviços de Saúde (CSS). Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Medical graduation at the Federal University of Espírito Santo, Brazil (1991); Medical Residence in Anesthesiology at the Ribeirão Preto Clinical Hospital of the University of São Paulo Medical School (from 1991 to 1993) and Specialization in Pain Clinic (1995); One year of fellowship in Physiopharmacology of Pain at INSERM, Paris, France (1996-1997) with the subject " Electrochemistry in vivo" under the supervision of Prof. Jean Paul Rivot; Master's Degree in Pharmacology at the UNIVERSITY OF SÃO PAULO MEDICAL SCHOOL, in Ribeirão Preto, Estate of São Paulo under the supervision of Prof. William Alves do Prado (1999); pHD in Anesthesiology at the University of São Paulo, under supervision of Prof Hazem Adel Ashmawi (2010); pos doctoral degree 2015. Currently works as pain specialist at Central Institute of Hospital das Clinicas of the University of Sao Paulo and oordinates the Pain Service at the Cancer Institute of the Estate of São Paulo Has experience in PAIN, acting on the following subjects: POSTOPERATIVE PAIN, CHONIC CANCER PAIN AND CHRONIC NON CANCER PAIN. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Nausea and vomiting affects 25-30% of patients after surgeries. In high-risk patients, this incidence can reach 70-80% of people. Identification of high-risk patients for PONV (through medical history and / or molecular testing) may restrict the number of potential candidates for a particular type of prophylactic anti-emetic therapy, indicating those most likely to benefit from the speci…
The incidence of nausea and vomiting after surgery is still significant, ranging from 20 to 50% in outpatient surgery and 70% in some surgical groups. Antiemetics with different mechanisms of action, used for preventing nausea after chemotherapy, has been proposed to treat nausea and vomiting after surgery. Aprepitant, a neurokinin inhibitor and palonasetron, blocking 5HT-3 receptors, ar…
The incidence of nausea and vomiting affects 25-30% of individuals after surgery and in high-risk patients, this incidence can reach 70-80%. The identification of individuals at high risk for postoperative nausea and vomiting (PONV) may restrict the number of potential candidates for a particular type of anti-emetic therapy, indicating those most likely to benefit from the effect of certa…
1. Background - Nausea and vomiting are amongst the most distressing symptoms in the postoperative setting. Its etiology is multifactorial and is associated with a number of risk factors that can be related or unrelated to the patients history. Examples of patient-related factors include age, gender, weight and history of postoperative nausea and vomiting, while surgery-related factors ar…
| 2 / 2 | Completed research grants |
| 2 / 2 | Completed scholarships in Brazil |
| 4 / 4 | All research grants and scholarships |
| Associated processes | |